Sucampo Pharmaceuticals, Inc. Strengthens Its Board of Directors

BETHESDA, MD--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced that Gayle Dolecek, P.D., M.P.H., has been appointed to its Board of Directors. Dr. Dolecek is currently Sucampo’s Senior Vice President of Research and Development.

MORE ON THIS TOPIC